BrainsWay Ltd. (TLV:BWAY)
Israel · Delayed Price · Currency is ILS · Price in ILA 2,767.00
+45.00 (1.65%)
At close: Dec 4, 2025
BrainsWay Employees
BrainsWay had 120 employees as of December 31, 2024. The number of employees decreased by 14 or -10.45% compared to the previous year.
Employees
120
Change (1Y)
-14
Growth (1Y)
-10.45%
Revenue / Employee
1.35M ILS
Profits / Employee
172.40K ILS
Market Cap
1.08B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 120 | -14 | -10.45% |
| Dec 31, 2023 | 134 | 0 | - |
| Dec 31, 2022 | 134 | 16 | 13.56% |
| Dec 31, 2021 | 118 | 18 | 18.00% |
| Dec 31, 2020 | 100 | -7 | -6.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Teva Pharmaceutical Industries | 35,686 |
| Danel (Adir Yeoshua) | 4,290 |
| Novolog (Pharm-Up 1966) | 936 |
| Kamada | 420 |
| InterCure | 320 |
| Bait Bakfar | 227 |
| Ilex Medical | 178 |
| SofWave Medical | 126 |
BrainsWay News
- 3 days ago - Brainsway Ltd Analyst and Investor Day Transcript - GuruFocus
- 4 days ago - Are Options Traders Betting on a Big Move in BrainsWay Stock? - Nasdaq
- 5 days ago - BrainsWay Ltd. (BWAY) Analyst/Investor Day Transcript - Seeking Alpha
- 11 days ago - BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company's Growth Strategy and Deep TMS™ Treatment December 1, 2025 - GlobeNewsWire
- 19 days ago - BrainsWay (BWAY) Kicks Off Clinical Trial for Alcohol Use Disorder Treatment - GuruFocus
- 19 days ago - BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder - GlobeNewsWire
- 23 days ago - BrainsWay: High Growth Set To Persist - Seeking Alpha
- 23 days ago - BrainsWay (BWAY) Receives Updated "Buy" Rating from Analysts | BWAY Stock News - GuruFocus